
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
203.650
Open
202.350
VWAP
191.41
Vol
3.35M
Mkt Cap
49.44B
Low
186.230
Amount
641.63M
EV/EBITDA(TTM)
9.47
Total Shares
263.92M
EV
64.18B
EV/OCF(TTM)
7.19
P/S(TTM)
0.86
The Allstate Corporation is a holding company for Allstate Insurance Company. The Company's business is conducted principally through Allstate Insurance Company and other subsidiaries. It is primarily engaged in the property and casualty insurance bu...Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
16.41B
+7.56%
3.711
-27.67%
16.86B
+7.32%
3.118
+93.66%
17.24B
+3.68%
4.310
+10.22%
Estimates Revision
The market is revisingDownwardthe revenue expectations for The Allstate Corporation (ALL) for FY2025, with the revenue forecasts being adjusted by -0.71%over the past three months. During the same period, the stock price has changed by0.36%.
Revenue Estimates for FY2025
Revise Downward

-0.71%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-6.45%
In Past 3 Month
Stock Price
Go Up

+0.36%
In Past 3 Month
15 Analyst Rating

23.94% Upside
Wall Street analysts forecast ALL stock price to riseover the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 231.23USD with a low forecast of183.00USD and a high forecast of279.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
2 Hold
1 Sell
Moderate Buy

23.94% Upside
Current: 186.570

Low
183.00
Averages
231.23
High
279.00
Keefe, Bruyette & Woods
Meyer Shields
Buy
Maintains
$235 → $240
2025-02-11
Reason
Keefe Bruyette analyst Meyer Shields raised the firm's price target on Allstate to $240 from $235 and keeps an Outperform rating on the shares. The firm expects substantial core loss ratio improvement to help bolster confidence in Allstate's normalized earnings growth outlook, the analyst tells investors in a research note.
Wells Fargo
Elyse Greenspan
Hold
Maintains
$186 → $187
2025-01-14
Reason
Wells Fargo analyst Elyse Greenspan raised the firm's price target on Allstate to $187 from $186 and keeps an Equal Weight rating on the shares. Discussing the insurance industry, Wells notes that for non-life insurance, the focus remains on cats, pricing, loss trend, reserves and margins. Domestically Q4 cats are above normal due to Milton, with international losses from Spanish floods. For Life insurance, the focus is on sales growth, rate commentary, Group results, and guides. Sales growth should continue to get attention, while group results are trending well, and life companies continue to return capital. Meanwhile, Brokers should continue to see good organic growth, the firm adds.
Keefe, Bruyette & Woods
Meyer Shields
Buy
Maintains
$235 → $243
2025-01-10
Reason
Keefe Bruyette raised the firm's price target on Allstate to $243 from $235 and keeps an Outperform rating on the shares as part of a Q4 earnings preview for the property and casualty sector. The results will include slowing written commercial and specialty premium growth, as well as "significant but manageable" reinsured catastrophe losses from hurricanes, the analyst tells investors in a research note. Keefe mostly raised Q4 catastrophe loads for property and casualty insurers citing "persistent Helene loss creep."
Barclays
Alex Scott
Sell
Maintains
$187 → $183
2025-01-06
Reason
Barclays lowered the firm's price target on Allstate to $183 from $187 and keeps an Underweight rating on the shares. As Barclays assesses the landscape for the insurance industry heading into 2025, it remains more optimistic on the life insurers as it sees improving free cash flow, benefits from higher interest rates, sizeable excess capital positions, strong group benefits earnings, and potential for further reinsurance and merger transactions. While property and casualty is a very high-quality business over the long term, we are at a tougher part of the underwriting cycle for property coverage, and casualty loss cost trend still poses a risk that will potentially prevent more favorable development, the analyst tells investors in a research note. As a result, the firm is more selective in its stock picks.
Piper Sandler
Paul Newsome
Buy
Maintains
$206 → $244
2024-11-26
Reason
Piper Sandler raised the firm's price target on Allstate to $244 from $206 and keeps an Overweight rating on the shares following quarterly results. The firm continues to be bullish on personal lines writers in general and Allstate in particular. Piper thinks today's hard market in personal lines is about as hard as it has ever been with price increases that it doesn't think have been as high ever.
Goldman Sachs
Alex Scott
Strong Buy
Maintains
$209 → $230
2024-11-15
Reason
Jefferies
Yaron Kinar
Strong Buy
Maintains
$231 → $267
2024-11-08
Reason
Jefferies raised the firm's price target on Allstate to $267 from $231 and keeps a Buy rating on the shares. The firm views the policy-in-force miss in Auto as timing driven, reflecting renewal pressure from rate, which should wane. The firm expects strong new business, leading to market share gains in Auto and Home, the analyst tells investors.
Morgan Stanley
Bob Huang
Buy
Maintains
$220 → $228
2024-11-07
Reason
Morgan Stanley raised the firm's price target on Allstate to $228 from $220 and keeps an Overweight rating on the shares and move the stock to the analyst's "Top Pick" in the group. Allstate will grow auto policy-in-force, or PIF, in 2025, contends the firm. While the firm thinks pricing will decelerate, the competitive environment will still be "relatively favorable," leading to efficient growth opportunities for Allstate in 2025, the analyst tells investors.
Keefe, Bruyette & Woods
Meyer Shields
Buy
Maintains
$222 → $225
2024-11-06
Reason
Wells Fargo
Elyse Greenspan
Hold
Maintains
$175 → $186
2024-11-05
Reason
Wells Fargo raised the firm's price target on Allstate (ALL) to $186 from $175 and keeps an Equal Weight rating on the shares. The firm notes the stock traded down post earnings as strong print was shadowed by continued sequential PIF decline despite further increase in ad spend. Wells believes the stock could be stuck until they show signs of PIF growth, especially with growth seen at Progressive (PGR).
Valuation Metrics
The current forward P/E ratio for Allstate Corp(ALL.N) is 11.41, compared to its 5-year average forward P/E of 1.75. For a more detailed relative valuation and DCF analysis to assess Allstate Corp 's fair value, click here.
Forward PE

N/A
5Y Average PE
1.75
Current PE
11.41
Overvalued PE
42.72
Undervalued PE
-39.21
Forward EV/EBITDA

N/A
5Y Average EV/EBITDA
2.67
Current EV/EBITDA
11.50
Overvalued EV/EBITDA
7.59
Undervalued EV/EBITDA
-2.25
Forward PS

Fair
5Y Average PS
0.71
Current PS
0.79
Overvalued PS
0.82
Undervalued PS
0.60
Financials
Annual
Quarterly
FY2024Q4
YoY :
+11.29%
16.51B
Total Revenue
FY2024Q4
YoY :
+30.48%
2.56B
Operating Profit
FY2024Q4
YoY :
+27.10%
1.89B
Net Income after Tax
FY2024Q4
YoY :
+26.75%
7.06
EPS - Diluted
FY2024Q4
YoY :
+43.41%
1.66B
Free Cash Flow
FY2024Q4
YoY :
+95.97%
13.60
FCF Margin - %
FY2024Q4
YoY :
+14.16%
11.45
Net Margin - %
FY2024Q4
18.12
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
19.9M
USD
3
3-6
Months
18.5M
USD
3
6-9
Months
50.9M
USD
5
0-12
Months
8.3M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
703.9K
Volume
6
6-9
Months
0.0
Volume
0
0-12
Months
648.5K
Volume
10
Bought
0-3
0
0.0
Volume
Months
3-6
4
1.1M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
16
1.5M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
16.0K
USD
2
6-9
Months
16.0K
USD
2
0-12
Months
16.0K
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ALL News & Events
Events Timeline
2025-04-01 (ET)
2025-04-01
11:27:09
Allstate completes sale of Employer Voluntary Benefits business

2025-04-01
11:19:17
The Standard completes acquisition of Allstate EVB business

2025-03-20 (ET)
2025-03-20
09:55:01
Early notable gainers among liquid option names on March 20th

2025-03-20
09:17:10
Allstate February catastrophe losses $92M or $73M after-tax

2025-03-11 (ET)
2025-03-11
12:46:42
Allstate names Andrea Carter as chief human resources officer

2025-02-26 (ET)
2025-02-26
17:07:00
Allstate authorizes $1.5B stock buyback, raises quarterly dividend 8.7%

2025-02-20 (ET)
2025-02-20
08:12:54
Allstate announces January catastrophe losses $1.08B

2025-01-30 (ET)
2025-01-30
15:51:07
Allstate to sell Group Health business to Nationwide for $1.25B in cash

2025-01-30
15:38:09
Allstate to sell Group Health unit to Nationwide Life Insurance for $1.25B

2025-01-30
15:32:53
Allstate to buy select Nationwide Life Insurance assets for $1.25B

2025-01-14 (ET)
2025-01-14
04:56:19
Allstate, Arity sued by Texas AG for 'unlawfully' collecting driver data


2025-01-08 (ET)
2025-01-08
16:54:39
California wildfires threaten already 'teetering' insurers, NY Times says


2024-11-21 (ET)
2024-11-21
07:36:03
Allstate estimates October catastrophe losses $286M or $226M, after-tax

News
4.5
04-02CNBCThursday’s big stock stories: What’s likely to move the market in the next trading session
8.0
04-02MarketWatchTariffs could increase car-insurance prices. Here are 3 moves to cut costs.
4.0
04-02CNBCInvesting around the trade war: These defensive, stable stocks should be immune
8.5
04-01NASDAQ.COMAllstate Closes Sale of One of Health and Benefits' Businesses
2.0
04-01NASDAQ.COMAllstate (ALL) Rises But Trails Market: What Investors Should Know
3.0
04-01NASDAQ.COMALL Quantitative Stock Analysis
8.0
03-31NASDAQ.COMAllstate's Preferred Stock, Series I Crosses Above 6% Yield Territory
3.0
03-29NASDAQ.COMALL Quantitative Stock Analysis
4.5
03-27MarketWatchThe stock market’s oversold rally is peaking — and so is the 10-year U.S. Treasury
2.0
03-26NASDAQ.COMWhy the Market Dipped But Allstate (ALL) Gained Today
3.0
03-22NASDAQ.COMALL Quantitative Stock Analysis
4.5
03-21CNBCThe stocks that are working as the market struggles over the past month
7.5
03-21NASDAQ.COM Allstate Reports $73M After-Tax Catastrophe Losses in February 2025
9.5
03-20CNBCFriday’s big stock stories: What’s likely to move the market in the next trading session
4.5
03-20NASDAQ.COMStocks Settle Lower on Economic Uncertainty
4.5
03-20MarketWatchThe stock market is riding an oversold rally for now. Here’s when it stalls out.
4.5
03-20NASDAQ.COMThursday Sector Leaders: Utilities, Financial
2.0
03-20NewsfilterAllstate survey: Americans express growing concern about their personal info at tax time – why identity protection may offer the best safeguards
2.0
03-17BenzingaSevere Storm System Brings Devastation: At Least 42 Dead, Power Outages, Widespread Damage Reported
2.0
03-17NASDAQ.COMHow Is Allstate’s Stock Performance Compared to Other P&C Insurers?
People Also Watch

AMSC
American Superconductor Corp
15.800
USD
-5.22%

FBMS
First Bancshares Inc (Mississippi)
33.810
USD
+0.48%

KRO
Kronos Worldwide Inc
6.690
USD
-4.15%

RCKT
Rocket Pharmaceuticals Inc
5.120
USD
-7.91%

OBK
Origin Bancorp Inc
30.350
USD
-3.53%

LQDA
Liquidia Corp
12.900
USD
-8.70%

ACMR
ACM Research Inc
20.300
USD
-9.17%

IRS
IRSA Inversiones y Representaciones SA
12.550
USD
-2.86%

OCFC
OceanFirst Financial Corp
15.070
USD
-3.09%

AMAL
Amalgamated Bank
26.410
USD
-2.62%
FAQ

What is Allstate Corp (ALL) stock price today?
The current price of ALL is 186.57 USD — it hasdecreased-9.13 % in the last trading day.

What is Allstate Corp (ALL)'s business?

What is the price predicton of ALL Stock?

What is Allstate Corp (ALL)'s revenue for the last quarter?

What is Allstate Corp (ALL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Allstate Corp (ALL)'s fundamentals?

How many employees does Allstate Corp (ALL). have?
